Patents by Inventor Lawren Wu

Lawren Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-tryptase antibodies, compositions thereof, and uses thereof
    Patent number: 11939396
    Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: March 26, 2024
    Assignee: Genentech, Inc.
    Inventors: Xiaocheng Chen, Mark Dennis, Janet Jackman, James T. Koerber, Mason Lu, Henry R. Maun, Kathila Rajapaksa, Saroja Ramanujan, Tracy Staton, Lawren Wu, Tangsheng Yi
  • CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
    Publication number: 20230331855
    Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.
    Type: Application
    Filed: March 3, 2023
    Publication date: October 19, 2023
    Inventors: Jed WILTZIUS, Ruben ALVAREZ RODRIGUEZ, Alice BAKKER, Lawren WU, Tara ARVEDSON
  • CHIMERIC RECEPTORS TO FLT3 AND METHODS OF USE THEREOF
    Publication number: 20230124464
    Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells to FLT3 are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the FLT3 antigen binding molecules and engineered immune cells.
    Type: Application
    Filed: May 23, 2022
    Publication date: April 20, 2023
    Inventors: Alice BAKKER, Lawren WU, Tara ARVEDSON, Jed J. WILTZIUS, Ruben Alvarez RODRIGUEZ
  • CHIMERIC RECEPTORS TO DLL3 AND METHODS OF USE THEREOF
    Publication number: 20210163621
    Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells to DLL3 are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the DLL3 antigen binding molecules and engineered immune cells.
    Type: Application
    Filed: April 10, 2019
    Publication date: June 3, 2021
    Applicants: AMGEN INC., KiTe Pharma, Inc.
    Inventors: Michael John Giffin, Melissa THOMAS, Christopher MURAWSKY, Ryan B. CASE, Lawren WU, Jed J. WILTZIUS, Ruben Alvarez RODRIGUEZ, Jun FENG
  • ANTI-TRYPTASE ANTIBODIES, COMPOSITIONS THEREOF, AND USES THEREOF
    Publication number: 20200325248
    Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.
    Type: Application
    Filed: June 30, 2020
    Publication date: October 15, 2020
    Inventors: Xiaocheng CHEN, Mark DENNIS, Janet JACKMAN, James T. KOERBER, Mason LU, Henry R. MAUN, Kathila RAJAPAKSA, Saroja RAMANUJAN, Tracy STATON, Lawren WU, Tangsheng YI
  • Anti-tryptase antibodies, compositions thereof, and uses thereof
    Patent number: 10752703
    Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: August 25, 2020
    Assignee: Genentech, Inc.
    Inventors: Xiaocheng Chen, Mark Dennis, Janet Jackman, James T. Koerber, Mason Lu, Henry R. Maun, Kathila Rajapaksa, Saroja Ramanujan, Tracy Staton, Lawren Wu, Tangsheng Yi
  • Anti-tryptase antibodies, compositions thereof, and uses thereof
    Patent number: 10738131
    Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: August 11, 2020
    Assignee: Genentech, Inc.
    Inventors: Xiaocheng Chen, Mark Dennis, Janet Jackman, James T. Koerber, Mason Lu, Henry R. Maun, Kathila Rajapaksa, Saroja Ramanujan, Tracy Staton, Lawren Wu, Tangsheng Yi
  • CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
    Publication number: 20200115457
    Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.
    Type: Application
    Filed: October 21, 2019
    Publication date: April 16, 2020
    Inventors: Jed WILTZIUS, Ruben ALVAREZ RODRIGUEZ, Alice BAKKER, Lawren WU, Tara ARVEDSON
  • Chimeric receptors and methods of use thereof
    Patent number: 10597456
    Abstract: Antigen binding molecules, chimeric receptors, and engineered immune cells are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: March 24, 2020
    Assignees: AMGEN INC., KITE PHARMA, INC.
    Inventors: Jed Wiltzius, Ruben Alvarez Rodriguez, Alice Bakker, Lawren Wu, Tara Arvedson
  • ANTI-TRYPTASE ANTIBODIES, COMPOSITIONS THEREOF, AND USES THEREOF
    Publication number: 20190367637
    Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.
    Type: Application
    Filed: August 19, 2019
    Publication date: December 5, 2019
    Inventors: Xiaocheng CHEN, Mark DENNIS, Janet JACKMAN, James T. KOERBER, Mason LU, Henry R. MAUN, Kathila RAJAPAKSA, Saroja RAMANUJAN, Tracy STATON, Lawren WU, Tangsheng YI
  • ANTI-TRYPTASE ANTIBODIES, COMPOSITIONS THEREOF, AND USES THEREOF
    Publication number: 20180230233
    Abstract: The invention provides compositions including anti-tryptase antibodies and pharmaceutical compositions thereof, as well as methods of using the same.
    Type: Application
    Filed: February 9, 2018
    Publication date: August 16, 2018
    Inventors: Xiaocheng CHEN, Mark DENNIS, Janet JACKMAN, James T. KOERBER, Mason LU, Henry R. MAUN, Kathila RAJAPAKSA, Saroja RAMANUJAN, Tracy STATON, Lawren WU, Tangsheng YI
  • ANTI-IL-13/IL-17 BISPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20170334985
    Abstract: The invention provides anti-IL-13/IL-17 bispecific antibodies, in particular, anti-IL13/IL17 AA, AF and FF antibodies and methods of using the same, including without limitation, methods of using the anti-IL-13/IL-17 bispecific antibodies for treating moderate to severe asthma and/or eosinophilic asthma.
    Type: Application
    Filed: February 23, 2017
    Publication date: November 23, 2017
    Applicant: Genentech, Inc.
    Inventors: LAWREN WU, JOSEPH R. ARRON, MICHAEL DILLON, DAVID F. CHOY, SUE SOHN, CHRISTOPH SPIESS, WHITNEY SHATZ
  • APOPTOTIC ANTI-IGE ANTIBODIES
    Publication number: 20140115729
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 24, 2014
    Applicant: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andrew Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • Apoptotic anti-IgE antibodies
    Patent number: 8632775
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: January 21, 2014
    Assignee: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andrew Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • Nucleic acid encoding apoptotic anti-IgE antibodies
    Patent number: 8618274
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: December 31, 2013
    Assignee: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andy Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • Methods of using apoptotic anti-IGE antibodies
    Patent number: 8586040
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Grant
    Filed: October 25, 2011
    Date of Patent: November 19, 2013
    Assignee: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andy Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • METHODS OF USING APOPTOTIC ANTI-IGE ANTIBODIES
    Publication number: 20120177635
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Application
    Filed: October 25, 2011
    Publication date: July 12, 2012
    Applicant: GENENTECH, INC.
    Inventors: LAWREN WU, MERCEDESZ BALAZS, HANS BRIGHTBILL, ANDY CHAN, YVONNE CHEN, ANAN CHUNTHARAPAL, MARK DENNIS, TERENCE WONG
  • Nucleic acid encoding apoptotic anti-ige antibodies
    Publication number: 20120178127
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Application
    Filed: October 25, 2011
    Publication date: July 12, 2012
    Applicant: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andrew Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • APOPTOTIC ANTI-IGE ANTIBODIES
    Publication number: 20120149881
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Application
    Filed: October 25, 2011
    Publication date: June 14, 2012
    Applicant: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andrew Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong
  • TRANSGENIC ANIMALS EXPRESSING HUMAN IGE-M1'
    Publication number: 20120144512
    Abstract: The present application relates to apoptotic anti-IgE antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use in the treatment of IgE-mediated disorders.
    Type: Application
    Filed: October 25, 2011
    Publication date: June 7, 2012
    Applicant: Genentech, Inc.
    Inventors: Lawren Wu, Mercedesz Balazs, Hans Brightbill, Andrew Chan, Yvonne Chen, Anan Chuntharapai, Mark Dennis, Terence Wong